Summary

Vaccines Europe represents a specialized group of global vaccine companies operating across Europe to drive innovation and recognition of life-course immunisation. The initiative aims to protect people against evolving health challenges by fostering continuous improvement. Through their work, members save approximately 154 million lives in the last half-century and show strong financial returns, with adult programmes returning up to 19 times their initial investment. Clinical trials in the European Union have reduced by 35% compared to 2000, while 98 vaccine candidates currently exist in pipeline for member companies. Most EU members spend less than half of their healthcare budget on immunisation, a challenge that vaccination Europe aims to overcome through targeted research. Additionally, regulatory approval takes over 6 years to reach eligible citizens in the 13 EU countries with new vaccines, a time often cited by health professionals as critical for national health systems.

Title

Home - Vaccines Europe

Description

An industry for healthy lives

Keywords

vaccines, more, europe, read, immunisation, access, vaccine, source, preferences, health, technical, storage, purpose, user, purposes, industry, vaccination

NS Lookup

A 34.77.128.68

Dates

Created 2026-04-14

Updated 2026-04-14

Summarized 2026-04-15